At-the-Market Equity Offerings - Summary of Active At-the-Market Equity Offering (Detail) - USD ($)										3 Months Ended		5 Months Ended	8 Months Ended
		May 02, 2025	Apr. 30, 2025	Mar. 31, 2025	Nov. 19, 2024	Oct. 30, 2024	Aug. 01, 2024	Jul. 31, 2024	Nov. 30, 2023	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2025	Jul. 31, 2024	Dec. 31, 2024
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement										$ 4,399,205,000	$ 137,152,000
Class A
At Market Equity Offerings [Line Items]
Cumulative shares sold under such sales agreement				246,537,000						246,537,000		246,537,000	246,537,000		226,138,000
October 2024 Sales Agreement
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement										$ 4,399,205,000
Cumulative shares sold under such sales agreement				51,296,132						51,296,132		51,296,132	51,296,132
October 2024 Sales Agreement | Subsequent Event
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement		$ 20,970,000,000
Cumulative shares sold under such sales agreement		58,384,669
October 2024 Sales Agreement | LLC, BTIG, LLC, Canaccord Genuity LLC, Cantor Fitzgerald & Co., Maxim Group LLC, Mizuho Securities USA LLC, and SG Americas Securities, LLC
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement												$ 18,598,636,000
October 2024 Sales Agreement | LLC, BTIG, LLC, Canaccord Genuity LLC, Cantor Fitzgerald & Co., Maxim Group LLC, Mizuho Securities USA LLC, and SG Americas Securities, LLC | Class A
At Market Equity Offerings [Line Items]
Agreement effective date						Oct. 30, 2024
Maximum aggregate offering price						$ 21,000,000,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares						2.00%
Maximum aggregate offering price remaining available for sale under such sales agreement	[1]			$ 2,367,648
October 2024 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC | Class A
At Market Equity Offerings [Line Items]
Date terminated/substantially depleted			Apr. 30, 2025
August 2024 Sales Agreement
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement										$ 0
Cumulative shares sold under such sales agreement				11,685,355						11,685,355		11,685,355	11,685,355
August 2024 Sales Agreement | TD Securities (USA) LLC, The Benchmark Company, LLC, BTIG, LLC, Canaccord Genuity LLC, Maxim Group LLC and SG Americas Securities, LLC
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement													$ 1,993,273,000
August 2024 Sales Agreement | TD Securities (USA) LLC, The Benchmark Company, LLC, BTIG, LLC, Canaccord Genuity LLC, Maxim Group LLC and SG Americas Securities, LLC | Class A
At Market Equity Offerings [Line Items]
Agreement effective date							Aug. 01, 2024
Maximum aggregate offering price							$ 2,000,000,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares							2.00%
August 2024 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC | Class A
At Market Equity Offerings [Line Items]
Date terminated/substantially depleted					Nov. 19, 2024
November 2023 Sales Agreement
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement										$ 0	$ 137,152,000
Cumulative shares sold under such sales agreement				12,720,770						12,720,770		12,720,770	12,720,770
November 2023 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC
At Market Equity Offerings [Line Items]
Net proceeds received from shares sold under such sales agreement														$ 747,025,000
November 2023 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC | Class A
At Market Equity Offerings [Line Items]
Agreement effective date									Nov. 30, 2023
Maximum aggregate offering price									$ 750,000,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares									2.00%
Date terminated/substantially depleted								Jul. 31, 2024

[1] As of May 2, 2025, the cumulative shares sold under the October 2024 Sales Agreement was 58,384,669 and the cumulative net proceeds received from shares sold under the October 2024 Sales Agreement was $20.97 billion. Refer to Note 14, Subsequent Events, for further discussion.